The Magazine for Sleep Professionals
Wednesday, September 9, 2026
ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]
Pear Therapeutics, Inc. announced that the Company and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the “Debtors”), each voluntarily filed for protection under chapter 11 (“Chapter 11”) of the U.S. Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy […]
It seemed like a foregone conclusion that Virtuox would snap up NovaSom’s assets at the scheduled bankruptcy auction. However, the auction was canceled after Novasom accepted a $5.5 million offer from SleepMed now owned by BioSerenity Inc. as of September 25th. Not familiar with BioSerenity? They are a high growth […]
NovaSom Inc., the home sleep testing company whose backers include TPG Biotech and Johnson & Johnson’s venture capital arm, has filed for bankruptcy with plans to sell its assets to Virtuox for $5.3 million as reported by The Wall Street Journal. NovaSom sought protection from creditors late Friday afternoon because […]
